COVID-19 causes supply-chain delays for New Zealand’s Douglas Pharmaceuticals

+News

COVID-19 causes supply-chain delays for New Zealand’s Douglas Pharmaceuticals

Martin
Johnston
Douglas Warehouse workers Henderson
Douglas Pharmaceuticals has at least three months’ stock of critical medicines and raw materials to buffer against COVID-19 supply-chain delays
All pharmaceutical companies worldwide are, to varying degrees, reliant on China The COVID-19 epidemic has caused Douglas Pharmaceuticals delays